① Qilin Zhengwei has completed its A-round financing of several ten million yuan, with funds allocated to technological iteration, facility construction, and market expansion. ② The company's hydrogen molecule face mask companion has cumulatively shipped nearly 50 million units, and the next-generation "Haipu Hydrogen" has completed mid-scale trials, with commercialization expected by the end of the year.
Zhejiang Qilin Zhengwei Medical Technology Co., Ltd. completed tens of millions of yuan in Series A financing, led by Meili Lingang Fund under Tiantu Investment. The funds will be used for technological iteration, base construction, and market expansion. Founded in 2022, the company is headquartered in Gongshu District, Hangzhou. Its founder, Li Qibin, established the company to solve the problem of stable hydrogen storage. Wang Jing, a professor at Jiangnan University, serves as the chief scientist. In its early stages, Qilin Zhengwei made breakthroughs in solid-state hydrogen storage and temperature control technology, achieving a hydrogen production rate of 800 milliliters per unit of facial mask伴侣. Currently, the company is developing a dual-gas release technology that combines hydrogen and carbon dioxide, improving transdermal efficiency by over 50%. Its new generation “Haipu Hydrogen” has completed pilot verification and is expected to be commercialized by the end of the year. So far, nearly 50 million units have been shipped, and the company has collaborated with companies such as Cosmeceuticals and Shiseido. Some customers order 500,000 to 1 million units per time.